查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842403

全球基因治疗培养基市场：市场规模、份额和趋势分析（按产品、载体类型、最终用途和地区划分），细分市场预测（2026-2033 年）

Gene Therapy Media Market Size, Share & Trends Analysis Report By Product (Specialty Media, Serum-free Media), By Vector Type (AAV, LV), By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

基因治疗媒体市场摘要

全球基因治疗培养基市场预计到 2025 年将价值 4.612 亿美元，预计到 2033 年将达到 16.138 亿美元，2026 年至 2033 年的复合年增长率为 17.1%。

这一增长是由基因治疗研究投入的增加、遗传性和慢性疾病的日益普遍以及细胞和基因疗法研发管线的不断扩大所推动的。

生物製药公司与研究机构之间的策略联盟，以及对创新治疗方法的有利监管支持，进一步支撑了市场的积极前景。

罕见遗传疾病疗法的成长和监管支持

基因治疗培养基产业的主要驱动力之一是人们日益关注罕见疾病和孤儿遗传疾病的治疗方法研发。全球数百万人患有超过7000种罕见疾病，其中大多数疾病仍缺乏有效的治疗方法。针对脊髓性肌肉萎缩症、血友病和遗传性视网膜疾病等疾病的临床试验数量不断增加，使得高品质、稳定性强且扩充性的基因治疗培养基成为支持研究和商业化生产的重要工具。

同时，美国FDA和欧洲药品管理局（EMA）等监管机构正在提供加速审批途径、孤儿药认定和奖励，以促进罕见疾病治疗领域的创新。这些支持性的法律规范正在缩短产品上市时间，并增加基因治疗生态系统内的投资和合作。随着更多治疗方法核准并进入市场，对符合GMP标准的稳定培养基配方的需求预计将会增长，这使得基因治疗培养基成为推进罕见遗传疾病治疗的关键组成部分。

提高病毒载体生产能力

病毒载体产能的提升是基因治疗培养基市场的主要驱动力。随着基因治疗计画的增加，製造商正大力投资建造大型生产设施，以满足对腺结合病毒（AAV）、慢病毒和逆转录病毒等病毒载体日益增长的需求。这些载体需要高度专业化和优化的细胞培养基，以确保高产量、稳定性和安全性。

从小规模实验室生产过渡到商业化生产，需要能够支持细胞旺盛生长、高转染效率和稳定病毒滴度的培养基配方。随着越来越多的基因疗法从临床试验走向商业化，对可扩展的、符合GMP规范的病毒载体生产平台及其配套专用培养基的需求预计将大幅增长。这将直接推动基因治疗培养基市场的成长。

目录

第一章 分析方法和范围

第二章执行摘要

第三章 市场因素、趋势与范围

  • 市场关联性展望
    • 母市场展望
    • 附随市场展望
  • 市场趋势与展望
  • 市场动态
    • 市场驱动因素的影响分析
    • 市场限制因素的影响分析
  • 商业环境分析
    • PESTLE分析
    • 波特五力分析

第四章 按产品进行业务分析

  • 产品仪錶板
  • 全球基因治疗培养基市场：按产品分類的差异分析
  • 全球基因治疗培养基市场规模及产品趋势分析（2021-2033）
  • 特殊培养基
    • 全球特种介质市场估计值与预测（2021-2033）
  • 无血清培养基
    • 全球无血清培养基市场估计值及预测（2021-2033）
  • 古典媒介
    • 全球古典文化媒体市场估计值与预测（2021-2033）
  • 其他的
    • 全球其他培养基市场估计值与预测（2021-2033）

第五章 依向量类型进行商业分析

  • 向量类型仪表板
  • 全球基因治疗培养基市场：依载体类型分類的变异分析
  • 全球基因治疗培养基市场规模及趋势分析（按载体类型划分）（2021-2033 年）
  • AAV製作
    • 全球AAV生产市场估计值与预测（2021-2033年）
  • LV 生产
    • 全球低压电气生产市场估计值与预测（2021-2033）

第六章 依最终用途进行业务分析

  • 终端用户仪錶板
  • 全球基因治疗培养基市场：依最终用途分類的差异分析
  • 全球基因治疗培养基市场规模及趋势分析（依最终用途划分）（2021-2033 年）
  • 製药和生物技术公司
    • 全球医药与生技市场估计值与预测（2021-2033）
  • CDMO/CRO
    • 全球CDMO/CRO市场估计值与预测（2021-2033年）
  • 研究和学术机构
    • 全球研究和学术机构市场估计值和预测（2021-2033）

7. 基因治疗培养基市场：区域估算和趋势分析（按产品、载体类型和最终用途划分）

  • 区域仪錶板
  • 市场规模预测及趋势分析（2021-2033）
  • 北美洲
    • 北美基因治疗媒体市场（2021-2033）
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲基因治疗媒体市场（2021-2033）
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区基因治疗媒体市场（2021-2033）
    • 日本
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲基因治疗媒体市场（2021-2033）
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲基因治疗媒体市场（2021-2033）
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司分类
  • 策略规划
  • 企业市场分析（2025 年）
  • 公司简介/上市公司
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Sartorius AG
    • Lonza
    • Danaher Corporation（Cytiva）
    • FUJIFILM Holdings Corporation
    • MP Biomedicals
    • Corning Incorporated
    • PAN-Biotech
    • Bio-Techne（R&D Systems, Inc.）
    • InVitria Inc
    • Florabio AS
    • Revvity
    • Virica
Product Code: GVR-4-68040-753-3

Gene Therapy Media Market Summary

The global gene therapy media market size was estimated at USD 461.2 million in 2025 and is projected to reach USD 1,613.8 million by 2033, growing at a CAGR of 17.1% from 2026 to 2033. This growth is driven by increasing investments in gene therapy research, the rising prevalence of genetic disorders and chronic diseases, and the expanding pipeline of cell and gene-based therapies.

Strategic collaborations between biopharmaceutical companies and research institutions and favorable regulatory support for innovative therapies further contribute to the strong market outlook.

Growth in Rare Genetic Disease Therapies & Regulatory Support

One of the main factors propelling the gene therapy media industry is the growing emphasis on creating treatments for uncommon and orphan genetic illnesses. Millions of people worldwide suffer from more than 7,000 rare diseases, the majority of which do not yet have adequate therapies. The rising number of clinical trials targeting conditions such as spinal muscular atrophy, hemophilia, and inherited retinal disorders creates substantial demand for high-quality, consistent, scalable gene therapy media to support research and commercial manufacturing.

At the same time, regulatory agencies such as the U.S. FDA and the European Medicines Agency (EMA) are providing accelerated pathways, orphan drug designations, and incentives to encourage innovation in rare disease therapies. This supportive regulatory framework reduces time-to-market and increases investment and partnerships across the gene therapy ecosystem. The demand for robust, GMP-compliant media formulations is expected to rise as more therapies gain approval and enter the market, positioning gene therapy media as a vital component in advancing treatments for rare genetic diseases.

Increasing Capacity for Viral Vector Production

The expansion of viral vector production capabilities is a key driver of the gene therapy media market. As the number of gene therapy programs grows, manufacturers invest heavily in large-scale production facilities to meet the increasing demand for viral vectors, such as adeno-associated virus (AAV), lentivirus, and retrovirus. These vectors require highly specialized and optimized cell culture media to ensure high yield, consistency, and safety.

The shift from small-scale laboratory production to commercial-scale manufacturing necessitates media formulations that support robust cell growth, high transfection efficiency, and stable viral titers. The need for scalable, GMP-compliant viral vector production platforms and the specialized media that support them is anticipated to increase dramatically as more gene therapies move from clinical trials to commercialization. This is expected to directly contribute to the growth of the gene therapy media market.

Global Gene Therapy Media Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global gene therapy media market based on product, vector type, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Specialty Media
  • Serum-free Media
  • Classical Media
  • Others
  • Vector Type Outlook (Revenue, USD Million, 2021 - 2033)
  • AAV Production
  • LV Production
  • Other Vectors
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical and Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs) & CROs
  • Research and Academic Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Vector Type
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Impact Analysis
      • 3.3.1.1. Growth in rare genetic disease therapies and regulatory support
      • 3.3.1.2. Increasing capacity for viral vector production
    • 3.3.2. Market Restraint Impact Analysis
      • 3.3.2.1. Technical and manufacturing challenges
      • 3.3.2.2. Long development timelines
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Gene Therapy Media Market Product, Movement Analysis
  • 4.3. Global Gene Therapy Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Specialty media
    • 4.4.1. Global specialty media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Serum-free Media
    • 4.5.1. Global serum-free media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Classical Media
    • 4.6.1. Global classical media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Global other media market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Vector Type Business Analysis

  • 5.1. Vector Type Segment Dashboard
  • 5.2. Global Gene Therapy Media Market Vector Type, Movement Analysis
  • 5.3. Global Gene Therapy Media Market Size & Trend Analysis, by Vector Type, 2021 to 2033 (USD Million)
  • 5.4. AAV Production
    • 5.4.1. Global AAV production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. LV Production
    • 5.5.1. Global LV production market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Gene Therapy Media Market End User, Movement Analysis
  • 6.3. Global Gene Therapy Media Market Size & Trend Analysis, by End User, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical and Biotechnology Companies
    • 6.4.1. Global pharmaceutical and biotechnology companies market estimates and
  • 6.5. Contract Development & Manufacturing Organizations (CDMOs) & CROs
    • 6.5.1. Global contract development & manufacturing organizations (CDMOs) & CROs market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Research and Academic Institutes
    • 6.6.1. Global research and academic institutes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Gene Therapy Media Market: Regional Estimates and Trend Analysis, by Product, Vector Type, & End-Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America gene therapy media market, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. gene therapy media market, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada gene therapy media market, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico gene therapy media market, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway gene therapy media market, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.5. Japan
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Singapore gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Australia gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Thailand gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.8. South Korea
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. South Korea gene therapy media market, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America gene therapy media market, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil gene therapy media market, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina gene therapy media market, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA gene therapy media market, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa gene therapy media market, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia gene therapy media market, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE gene therapy media market, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait gene therapy media market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Sartorius AG
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Danaher Corporation (Cytiva)
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. FUJIFILM Holdings Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. MP Biomedicals
      • 8.4.7.1. Overview
      • 8.4.7.2. Product Benchmarking
      • 8.4.7.3. Strategic Initiatives
    • 8.4.8. Corning Incorporated
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. PAN-Biotech
      • 8.4.9.1. Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. Bio-Techne (R&D Systems, Inc.)
      • 8.4.10.1. Overview
      • 8.4.10.2. Product Benchmarking
      • 8.4.10.3. Strategic Initiatives
    • 8.4.11. InVitria Inc
      • 8.4.11.1. Overview
      • 8.4.11.2. Product Benchmarking
      • 8.4.11.3. Strategic Initiatives
    • 8.4.12. Florabio AS
      • 8.4.12.1. Overview
      • 8.4.12.2. Product Benchmarking
      • 8.4.12.3. Strategic Initiatives
    • 8.4.13. Revvity
      • 8.4.13.1. Overview
      • 8.4.13.2. Product Benchmarking
      • 8.4.13.3. Strategic Initiatives
    • 8.4.14. Virica
      • 8.4.14.1. Overview
      • 8.4.14.2. Product Benchmarking
      • 8.4.14.3. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 4. Global Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 5. Global Gene Therapy Media Market, End use, 2021 - 2033 (USD Million)
  • Table 6. Global Gene Therapy Media Market, by Region, 2021 - 2033 (USD Million)
  • Table 7. North America Gene Therapy Media Market, by Country, 2021 - 2033 (USD Million)
  • Table 8. North America Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 9. North America Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 10. North America Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 11. North America Gene Therapy Media Market, by End user, 2021 - 2033 (USD Million)
  • Table 12. U.S. Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 13. U.S. Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 14. U.S. Gene Therapy Media Market, by End user, 2021 - 2033 (USD Million)
  • Table 15. Canada Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 16. Canada Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 17. Canada Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 18. Mexico Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 19. Mexico Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 20. Mexico Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 21. Europe Gene Therapy Media Market, by Country, 2021 - 2033 (USD Million)
  • Table 22. Europe Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 23. Europe Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 24. Europe Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 25. Germany Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 26. Germany Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 27. Germany Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 28. UK Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 29. UK Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 30. UK Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 31. France Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 32. France Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 33. France Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 34. Italy Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 35. Italy Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 36. Italy Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 37. Spain Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 38. Spain Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 39. Spain Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 40. Denmark Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 41. Denmark Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 42. Denmark Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 43. Norway Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 44. Norway Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 45. Norway Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 46. Sweden Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 47. Sweden Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 48. Sweden Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific Gene Therapy Media Market, by Country, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 51. Asia Pacific Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 52. Asia Pacific Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 53. China Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 54. China Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 55. China Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 56. Japan Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 57. Japan Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 58. Japan Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 59. India Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 60. India Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 61. India Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 62. South Korea Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 63. South Korea Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 64. South Korea Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 65. Australia Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 66. Australia Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 67. Australia Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 68. Thailand Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 69. Thailand Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 70. Thailand Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 71. Latin America Gene Therapy Media Market, by Country, 2021 - 2033 (USD Million)
  • Table 72. Latin America Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 73. Latin America Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 74. Latin America Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 75. Brazil Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 76. Brazil Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 77. Brazil Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 78. Argentina Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 79. Argentina Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 80. Argentina Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 81. Middle East and Africa Gene Therapy Media Market, by Country, 2021 - 2033 (USD Million)
  • Table 82. Middle East and Africa Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 83. Middle East and Africa Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 84. Middle East and Africa Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 85. South Africa Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 86. South Africa Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 87. South Africa Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 90. Saudi Arabia Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 91. UAE Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 92. UAE Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 93. UAE Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 95. Kuwait Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 96. Kuwait Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Gene therapy media market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validation & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot - 1
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 Gene therapy media market: Product outlook key takeaways
  • Fig. 19 Gene therapy media market: Product movement analysis
  • Fig. 20 Specialty media market, 2021 - 2033 (USD Million)
  • Fig. 21 Serum-free Media market, 2021 - 2033 (USD Million)
  • Fig. 22 Classical media market, 2021 - 2033 (USD Million)
  • Fig. 23 Others market, 2021 - 2033 (USD Million)
  • Fig. 24 Gene therapy media market: Vector type outlook key takeaways
  • Fig. 25 Gene therapy media market: Vector type movement analysis
  • Fig. 26 AAV production market, 2021 - 2033 (USD Million)
  • Fig. 27 LV production market, 2021 - 2033 (USD Million)
  • Fig. 28 Others production market, 2021 - 2033 (USD Million)
  • Fig. 29 Gene therapy media market: End Use outlook key takeaways
  • Fig. 30 Gene therapy media market: End Use movement analysis
  • Fig. 31 Pharmaceutical and biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 32 Contract Development & Manufacturing Organizations (CDMOs) & CROs market, 2021 - 2033 (USD Million)
  • Fig. 33 Research and Academic Institutes market, 2021 - 2033 (USD Million)
  • Fig. 34 Regional marketplace outlook, 2025 & 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 North America gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 U.S. gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Canada gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Mexico gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Europe gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Germany gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 UK gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 France gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Italy gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Spain gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Denmark gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Sweden gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Japan gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 China gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 India gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 South Korea gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Australia gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Thailand gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Latin America gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Brazil gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Argentina gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 MEA gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Africa gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Saudi Arabia gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 UAE gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Kuwait gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Market position analysis